GNB1 and colon adenocarcinoma: Approximately 30%, 20%, 60%, 57%, 56%, and 55% COAD patients have had the similar promoter methylation levels of CXCL12, CXCL8, AGT, GNB1, GNG4, and CXCL1, respectively, as examined in case of the normal controls.